FENNEC PHARMACEUTICALS INC. Other Non-Current Assets
FENNEC PHARMACEUTICALS INC. (FENC) had Other Non-Current Assets of $666.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Noncurrent $666.00K.
- 2026-03-31: Other Assets, Noncurrent $691.00K.
- 2025-12-31: Other Assets, Noncurrent $717.00K.
- 2025-09-30: Other Assets, Noncurrent $743.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $666.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $691.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $717.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $743.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $768.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $794.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $822.00K 10-K · filed 2026-03-27 | $2.44M 10-K · filed 2025-03-26 |
| 2024-09-30 | $956.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $989.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $816.00K 10-K · filed 2025-03-26 | $6.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |